Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010

Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015

Published:2016-12-23 Issue:3 Volume:64 Page:364-367
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Appiah Grace D¹²,Chaves Sandra S²,Kirley Pam D³,Miller Lisa⁴,Meek James⁵,Anderson Evan⁶,Oni Oluwakemi⁷,Ryan Patricia⁸,Eckel Seth⁹,Lynfield Ruth¹⁰,Bargsten Marisa¹¹,Zansky Shelley M¹²,Bennett Nancy¹³,Lung Krista¹⁴,McDonald-Hamm Christie¹⁵,Thomas Ann¹⁶,Brady Diane¹⁷,Lindegren Mary L¹⁸,Schaffner William¹⁸,Hill Mary¹⁹,Garg Shikha²,Fry Alicia M²,Campbell Angela P²

Affiliation:

1. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia

2. Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia

3. California Emerging Infections Program, Oakland

4. Colorado Department of Public Health and Environment, Denver

5. Connecticut Emerging Infections Program, Yale School of Public Health, New Haven

6. Departments of Pediatrics and Medicine, Emory University School of Medicine, and Atlanta Veterans Affairs Medical Center, Atlanta, Georgia

7. Iowa Department of Health, Des Moines

8. Maryland Department of Health and Mental Hygiene, Baltimore

9. Michigan Department of Health and Human Services, Lansing

10. Minnesota Department of Health, St Paul

11. New Mexico Department of Health, Santa Fe

12. New York State Department of Health, Albany

13. University of Rochester School of Medicine and Dentistry, Rochester, New York

14. Ohio Department of Health, Columbus

15. Oklahoma Department of Health, Oklahoma City

16. Oregon Department of Public Health, Portland

17. Rhode Island Department of Health, Providence

18. Vanderbilt University School of Medicine, Nashville, Tennessee

19. Utah Department of Health, Salt Lake City

Abstract

Abstract Using population-based surveillance data, we analyzed antiviral treatment among hospitalized patients with laboratory-confirmed influenza. Treatment increased after the influenza A(H1N1) 2009 pandemic from 72% in 2010–2011 to 89% in 2014–2015 (P < .001). Overall, treatment was higher in adults (86%) than in children (72%); only 56% of cases received antivirals on the day of admission.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/64/3/364/32926799/ciw745.pdf

Reference12 articles.

1. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials;Dobson;Lancet,2015

2. Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants;Lipsitch;Clin Infect Dis,2013

3. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09;Louie;Clin Infect Dis,2012

4. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data;Muthuri;Lancet Respir Med,2014

5. Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America;Harper;Clin Infect Dis,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza-Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012–2019;Clinical Infectious Diseases;2024-08-22

2. Trends in Outpatient Influenza Antiviral Use Among Children and Adolescents in the United States;Pediatrics;2023-11-13

3. Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020;Eurosurveillance;2023-01-26

4. Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015–2019;Open Forum Infectious Diseases;2022-12-19

5. Assessment of Temporal Patterns and Patient Factors Associated With Oseltamivir Administration in Children Hospitalized With Influenza, 2007-2020;JAMA Network Open;2022-09-23